🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsTirzepatide titration: 2.5→5→7.5→10→12.5→15mg guide Page 5

Tirzepatide titration: 2.5→5→7.5→10→12.5→15mg guide

Dr.Martinez Mon, Feb 19, 2024 at 5:20 PM 181 replies 34,127 viewsPage 5 of 20
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Feb 28, 2024 at 8:04 AM#21
Dr.SleepRoch said:
It helps to ask what evidence would change your mind before you look at any.

Adding the part of the answer the thread has not reached. The trials generally allowed a step to be held or reduced and then retried, and people who did that mostly arrived at the same place a few weeks later. The end point of the ladder is set by tolerability, not by a schedule, and there is no evidence that reaching the top faster produces a better outcome.

Last edited: Feb 28, 2024 at 2:04 PM
8 8SallyK_inj, CryptoCarl, MariaRD and 5 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Mar 1, 2024 at 12:38 PM#22

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Mar 1, 2024 at 1:38 PM
7 7DoseLogDan, SleepFixSam, PurityPaulOR and 4 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Mar 3, 2024 at 5:11 PM#23

Following on from Dr.SleepRoch — and this may be the naive question:

What the trials actually did with participants who could not tolerate a step, because that is the situation I am in and the protocol summaries skip it?

6 6stefan_berlin, Dr.EM_Chicago, pete_RVA and 3 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Mar 5, 2024 at 9:43 PM#24
raj_cambridge said:
Keep the original post as written when you update it, and add the correction underneath.

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

5 5bbq_ray_KC, oliver_london, tane_welly and 2 others
Reply Quote Save Share Report
SleepFixSam
Member
212
678
Nov 2024
Hawaii
Mar 8, 2024 at 2:14 AM#25
raj_cambridge said:
Keep the original post as written when you update it, and add the correction underneath.

Agreed on the arithmetic, with one condition: holding indefinitely at a dose that is not doing anything is not patience, it is a stall with a nice name. The distinction is whether appetite has changed at all at the current step.

4 4fiona_VT, denise_HTX, raj_cambridge and 1 other
Reply Quote Save Share Report
13456720

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register